The trials and tribulations of determining HbA_1c targets for diabetes mellitus.

ABSTRACT: Glycated haemoglobin (HbA_1c) is considered the gold standard for predicting glycaemia-associated risks for the microvascular and macrovascular complications of diabetes mellitus over 5-10 years. The value of HbA_1c in the care of patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) is unassailable, yet HbA_1c targets remain contentious. Guidelines from diabetes care organizations recommend conflicting HbA_1c targets - generally between 6.5% and 8%. However, all such organizations advocate for individualization of HbA_1c targets, leaving both health-care providers and their patients confused about what HbA_1c target is appropriate in an individual patient. In this Review, we outline the landmark T1DM a

SUBMITTER: Klein KR 

PROVIDER: S-EPMC11653296 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature